Table 2. Clinical phenotype of afected mutation carriers.
Patient, (gender) | Clinical phenotype |
---|---|
Proband, (F) | Syncope, Ventricular tachycardia and fibrillation, bradycardia and paroxysmal atrial fibrillation. |
II:4 (F) | Abnormal basal ECG. Development of type 1 BrS after flecainide test. |
II:8 (F) | Permanent atrial fibrillation |
III:1 (M) | Abnormal basal ECG. Development of type 1 BrS after flecainide test. |
III:6 (M) | Syncope. |
BrS: Brugada Syndrome. ECG: Electrocardiogram, F: female, M: male.